Monomethylarsonous acid inhibits endothelial nitric oxide synthase activity

Daigo Sumi, Keiko Taguchi, Yang Sun, Yasuhiro Shinkai, Yoshito Kumagai

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Inorganic arsenic undergoes extensive reduction and oxidative methylation in cells to yield a reactive metabolite of inorganic arsenic monomethylarsonous acid (MMAIII), which has a high reactivity toward vicinal thiols. Our epidemiological study in an endemic area of chronic arsenic poisoning and in experiments with rabbits exposed to arsenic revealed that arsenic exposure results in a reduction of systemic nitric oxide (NO) production. In this study, we examined the effect of MMAIII on endothelial NO synthase (eNOS) activity. With the membrane fraction of bovine aortic endothelial cells (BAEC), it was found that MMAIII with an IC50 value of 2.1 μM was a potent inhibitor of eNOS, whereas inorganic arsenic and their methylated metabolites had no effect on eNOS activity. Interestingly, addition of dithiothreitol markedly blocked the MMAIII-induced inhibition of eNOS activity. This report is the first to suggest that MMAIII interacts with eNOS protein through presumably vicinal thiols, leading to decreased eNOS activity.

Original languageEnglish
Pages (from-to)728-730
Number of pages3
JournalJournal of Health Science
Issue number6
Publication statusPublished - 2005 Dec
Externally publishedYes


  • Arsenic
  • Endothelial nitric oxide synthase
  • Monomethylarsonous acid

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis


Dive into the research topics of 'Monomethylarsonous acid inhibits endothelial nitric oxide synthase activity'. Together they form a unique fingerprint.

Cite this